First a shot to lose weight, then a pill to keep it off.

A recent FDA approval means consumers now have to GLP-1 weight loss pills to choose from as an alternative to the traditional ...

Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...

CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences ...

From once-a-week insulin to once-a-month weight loss injections, a new era of convenience is reshaping how doctors treat ...

Taking GLP-1s once meant injecting a shot with a monthly price tag of $1,000. Today, patients interested in the wildly popular weight-loss drugs can choose among different types of injectables and ...

GLP-1 drugs are fueling a surge in direct-to-consumer medications. But convenience may be replacing coordination—and creating ...

GLP-1s have quickly become one of the most popular types of weight loss drug in America. Nearly 1 in 5 people have taken them ...

Gan & Lee Pharmaceuticals (hereinafter referred to as "Gan & Lee", SSE: 603087) announced the signing of an exclusive ...

The food and beverage industry should view the rise of GLP-1 drugs as net positive and begin to position their products to ...

The European Medicines Agency (EMA) has approved an update to the product information of Wegovy injection, allowing it to be delivered to patients at controlled temperatures of up to 30°C for up to 48 ...

Drugmakers Novo Nordisk and Eli Lilly and Company have transformed the landscape of chronic weight loss management with the ...